Form D · Other
PureWave Hydrogen Corp.
Denver, CO · CIK 0002032988
Offering snapshot reported Aug 12, 2024 · SEC filing
- Reported sold
- $455K Offering amount: $455K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 24, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 12, 2024 | Initial | $455,000 | No comparison | 2 | SEC filing |
| Aug 7, 2024 | Initial | $35,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-521203
The Issuer issued an aggregate of 9,100,000 common shares at a deemed value of USD$0.05 per share in satisfaction of certain debts pursuant to Debt Settlement Agreements.
Source: Form D, filed Aug 12, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Frascogna | Director |
| Bruce Nurse | Director |
| Robert B Price | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
3400 Bayaud Avenue, Suite 400
Denver, CO, 80209
Denver, CO, 80209